Encarna Adrover

2.3k citations
40 papers · 1.1k indexed · h-index 14
Topics
Breast Cancer Treatment Studies (21 papers)Cancer Treatment and Pharmacology (19 papers)HER2/EGFR in Cancer Research (17 papers)

In The Last Decade

Encarna Adrover

39 papers receiving 1.1k citations

Peers

Encarna Adrover
Comparison fields: 5 of 82
  • Oncology 864
  • Cancer Research 366
  • Molecular Biology 297
  • Pulmonary and Respiratory Medicine 177
  • Genetics 113
Replace Davide Lombardi with:
Davide Lombardi Italy
Eleni Timotheadou Greece
Vicente Guillém Spain
Claudia Andreetta Italy
Andrea Michelotti Italy
Rebecca Feldman United States
Antonio Durando Italy
Yoshiya Horimoto Japan
Editta Baldini Italy
Maki Tanioka Japan
Encarna Adrover relative to Davide Lombardi Italy Davide Lombardi's profile →
Citations per field
00.5×2.5×
Davide Lombardi · 1×
Citations per year

Countries citing papers authored by Encarna Adrover

Since Specialization
Citations

This map shows the geographic impact of Encarna Adrover's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Encarna Adrover with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Encarna Adrover more than expected).

Fields of papers citing papers by Encarna Adrover

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Encarna Adrover. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Encarna Adrover. The network helps show where Encarna Adrover may publish in the future.

Co-authorship network of co-authors of Encarna Adrover

This figure shows the co-authorship network connecting the top 25 collaborators of Encarna Adrover. A scholar is included among the top collaborators of Encarna Adrover based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Encarna Adrover. Encarna Adrover is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 72
3 188
4 39
5 1
6 7
7 12
8
Epidemiología del melanoma cutáneo
0
9 8
10 3
11 139
12 2
13 12
14 156
15 90
16 11
17 30
18 53
19 2
20 61

About Encarna Adrover

Encarna Adrover is a scholar working on Cancer Research, Oncology and Dermatology, having authored 40 papers that have together received 1.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (21 papers), Cancer Treatment and Pharmacology (19 papers) and HER2/EGFR in Cancer Research (17 papers). The work is most often cited by research in Oncology (864 citations), Cancer Research (366 citations) and Reproductive Medicine (87 citations). Encarna Adrover has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include Antonio Casado, Miguel Martín, Gloria Peiró, Enrique Lerma, Fernando Ortiz-Martínez, Laura Sánchez-Tejada, Alberto Gallardo, Daniel Escuín, Ariadna Tibau and A. Barnadas. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Brain Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026